EW•benzinga•
Edwards Lifesciences Sees Q2 Adj EPS $0.59-$0.65 vs $0.62 Est; Sees Sales $1.450B-$1.530B vs $1.46B Est
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 23, 2025 by benzinga